In the News
Forbes: Caribou, A CRISPR Genome-Editing Company, Is Going To Share Ideas With DuPont
Caribou, the genome engineering company spun off from Jennifer Doudna’s CRISPR lab at Berkeley three years ago, announced today that it has agreed to a cross-licensing deal with DuPont , the industrial-chemicals company.
Genome Web: DuPont, Caribou Biosciences Ink Strategic Alliance on CRISPR, Cross-License IP
DuPont and Caribou Biosciences today announced a strategic alliance focused on agricultural applications of CRISPR/Cas9 genome editing.
Xconomy: West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More
We were stuck for a couple days in a Nobel vortex. Speculation about a Nobel Prize in chemistry for University of California, Berkeley scientist Jennifer Doudna and her gene-editing research partner, Emmanuelle Charpentier, swirled and swirled until everyone following it got a bit dizzy.
Berkeley News: Doudna receives Women in Science Award from L’Oreal-UNESCO
UC Berkeley professor Jennifer Doudna, who invented a gene-editing tool that has taken the research world by storm, was named one of five laureates of the 2016 L’Oréal-UNESCO for Women in Science Awards in the field of life sciences.
Chemical & Engineering News: The 2015 Top 20 Drugs in the Pipeline
While anticipation mounts that the FDA may rubber stamp a gene therapy technique for the first time within the next couple of years, excitement about a new, simple and highly-precise gene editing technique is reaching fever pitch.